The weekly litigation news digest is live. Subscribe now

Methods And Compositions For Delivering Mrna Coded Antibodies

Patent No. EP2970456 (titled "Methods And Compositions For Delivering Mrna Coded Antibodies") was filed by Shire Human Genetic Therapies on Mar 14, 2014. The application was issued on May 19, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
EIPFeb 21, 2022EIP
STRAWMANFeb 18, 2022MAIWALD
STRAWMANFeb 18, 2022VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
WITHERS & ROGERSFeb 18, 2022TOMBLING
GLAXOSMITHKLINEFeb 18, 2022HITCHCOCK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2970456

SHIRE HUMAN GENETIC THERAPIES
Application Number
EP14717945A
Filing Date
Mar 14, 2014
Status
Granted And Under Opposition
Apr 16, 2021
Publication Date
May 19, 2021